• Viral infections

Stavudine Generic Name & Formulations

General Description

Stavudine 15mg, 20mg, 30mg, 40mg; caps.

Pharmacological Class

Nucleoside analogue (reverse transcriptase inhibitor).

How Supplied

Contact supplier

Stavudine Indications


HIV-1 infection.

Stavudine Dosage and Administration


≥60kg: 40mg every 12hrs; <60kg: 30mg every 12hrs. Renal impairment: ≥60kg (CrCl 26–50mL/min): 20mg every 12hrs; (CrCl 10–25mL/min): 20mg every 24hrs. <60kg (CrCl 26–50mL/min): 15mg every 12hrs; (CrCl 10–25mL/min): 15mg every 24hrs. Hemodialysis: ≥60kg: 20mg every 24hrs; <60kg: 15mg every 24hrs. Coincide dose for end of dialysis and give at same time of day on non-dialysis days.


≤13 days: 0.5mg/kg every 12hrs. ≥14 days: (<30kg): 1mg/kg every 12hrs; (≥30kg): use adult dose. Renal impairment: insufficient data.

Stavudine Contraindications


Concomitant didanosine.

Stavudine Boxed Warnings

Boxed Warning

Lactic acidosis and hepatomegaly with steatosis. Pancreatitis.

Stavudine Warnings/Precautions


Suspend if lactic acidosis or hepatotoxicity (eg, hepatomegaly and steatosis) occurs. Women, obesity, or prolonged nucleoside exposure: increased risk of toxicity. Pre-existing liver dysfunction, hepatitis, or other risk factors of liver disease; monitor. Increased risk of peripheral neuropathy in advanced HIV disease, history of peripheral neuropathy, or when concomitant neurotoxic drugs; monitor and consider permanent discontinuation if develops. Suspend if pancreatitis is suspected; if confirmed may restart with caution and monitor closely. Monitor for signs/symptoms of lipoatrophy. Renal impairment. Elderly. Pregnancy. Nursing mothers: not recommended.

Stavudine Pharmacokinetics

See Literature

Stavudine Interactions


Avoid concomitant zidovudine. Increased risk of pancreatitis, hepatotoxicity, severe peripheral neuropathy with hydroxyurea; avoid. Caution with doxorubicin, ribavirin. Monitor for treatment-associated toxicities with interferon-alpha with or without ribavirin.

Stavudine Adverse Reactions

Adverse Reactions

Headache, diarrhea, nausea, vomiting, peripheral neurologic symptoms, rash, elevated liver enzymes, elevated amylase; pancreatitis, lactic acidosis or severe hepatomegaly with steatosis, lipoatrophy, immune reconstitution syndrome.

Stavudine Clinical Trials

See Literature

Stavudine Note


Formerly known under the brand name Zerit. Register pregnant patients exposed to stavudine by calling (800) 258-4263.

Stavudine Patient Counseling

See Literature